Cargando…

Urinary Potassium Excretion, Fibroblast Growth Factor 23, and Incident Hypertension in the General Population-Based PREVEND Cohort

High plasma fibroblast growth factor 23 (FGF23) and low potassium intake have each been associated with incident hypertension. We recently demonstrated that potassium supplementation reduces FGF23 levels in pre-hypertensive individuals. The aim of the current study was to address whether 24-h urinar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yeung, Stanley M. H., Hoorn, Ewout J., Rotmans, Joris I., Gansevoort, Ron T., Bakker, Stephan J. L., Vogt, Liffert, de Borst, Martin H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8707837/ https://www.ncbi.nlm.nih.gov/pubmed/34960084 http://dx.doi.org/10.3390/nu13124532

Ejemplares similares

Urinary potassium excretion and mortality risk in community-dwelling individuals with and without obesity
por: Yeung, Stanley M H, et al.
Publicado: (2022)

Dietary potassium and the kidney: lifesaving physiology
por: Wei, Kuang-Yu, et al.
Publicado: (2020)

Urinary albumin excretion and cancer risk: the PREVEND cohort study
por: Luo, Li, et al.
Publicado: (2023)

Separating the effects of 24-hour urinary chloride and sodium excretion on blood pressure and risk of hypertension: Results from PREVEND
por: van der Leeuw, Joep, et al.
Publicado: (2020)

Fibroblast Growth Factor 23 and Risk of New Onset Heart Failure With Preserved or Reduced Ejection Fraction: The PREVEND Study
por: Binnenmars, S. Heleen, et al.
Publicado: (2022)

Effects of Potassium or Sodium Supplementation on Mineral Homeostasis: A Controlled Dietary Intervention Study
por: Humalda, Jelmer K, et al.
Publicado: (2020)

Sex-specific associations between potassium intake, blood pressure, and cardiovascular outcomes: the EPIC-Norfolk study
por: Wouda, Rosa D, et al.
Publicado: (2022)

Fibroblast growth factor 23 and new-onset chronic kidney disease in the general population: the Prevention of Renal and Vascular Endstage Disease (PREVEND) study
por: De Jong, Maarten A, et al.
Publicado: (2020)

Personalizing potassium management in patients on haemodialysis
por: Wouda, Rosa D, et al.
Publicado: (2020)

Prevalence and Effects of Functional Vitamin K Insufficiency: The PREVEND Study
por: Riphagen, Ineke J., et al.
Publicado: (2017)

Predictors of Progression in Albuminuria in the General Population: Results from the PREVEND Cohort
por: Scheven, Lieneke, et al.
Publicado: (2013)

Urinary Calcium Excretion and Risk of Chronic Kidney Disease in the General Population
por: Taylor, Jacob M., et al.
Publicado: (2016)

Potassium and the kidney: a reciprocal relationship with clinical relevance
por: Wieërs, Michiel L. A. J., et al.
Publicado: (2022)

Cardiovascular and renal multimorbidity increase risk of atrial fibrillation in the PREVEND cohort
por: Van Deutekom, Colinda, et al.
Publicado: (2023)

Body fat estimates from bioelectrical impedance equations in cardiovascular risk assessment: The PREVEND cohort study
por: Byambasukh, Oyuntugs, et al.
Publicado: (2019)

Higher Sodium Intake Assessed by 24 Hour Urinary Sodium Excretion Is Associated with Non-Alcoholic Fatty Liver Disease: The PREVEND Cohort Study
por: van den Berg, Eline H., et al.
Publicado: (2019)

Effect of sodium bicarbonate supplementation on the renin-angiotensin system in patients with chronic kidney disease and acidosis: a randomized clinical trial
por: Bovée, Dominique M., et al.
Publicado: (2020)

Heart Rate Variability and Its Relation to Chronic Kidney Disease: Results From the PREVEND Study
por: Thio, Christian H.L., et al.
Publicado: (2018)

Phosphate and fibroblast growth factor 23 in diabetes
por: van der Vaart, Amarens, et al.
Publicado: (2021)

Clustering of cardiovascular and renal comorbidities and risk of incident atrial fibrillation in the community-based PREVEND cohort
por: Van Deutekom, C, et al.
Publicado: (2023)

High selenium levels associate with reduced risk of mortality and new‐onset heart failure: data from PREVEND
por: Al‐Mubarak, Ali A., et al.
Publicado: (2022)

Fibroblast Growth Factor 23 and Adverse Clinical Outcomes in Type 2 Diabetes: a Bitter-Sweet Symphony
por: Yeung, Stanley M. H., et al.
Publicado: (2020)

Circulating peroxiredoxin 4 and type 2 diabetes risk: the Prevention of Renal and Vascular Endstage Disease (PREVEND) study
por: Abbasi, Ali, et al.
Publicado: (2014)

Indomethacin Reduces Glomerular and Tubular Damage Markers but Not Renal Inflammation in Chronic Kidney Disease Patients: A Post-Hoc Analysis
por: de Borst, Martin H., et al.
Publicado: (2012)

Relative fat mass, a new index of adiposity, is strongly associated with incident heart failure: data from PREVEND
por: Suthahar, Navin, et al.
Publicado: (2022)

Plasma ApoE elevations are associated with NAFLD: The PREVEND Study
por: van den Berg, Eline H., et al.
Publicado: (2019)

The Urinary Excretion of Uromodulin is Regulated by the Potassium Channel ROMK
por: Schiano, Guglielmo, et al.
Publicado: (2019)

Circulating FGF21 Concentration, Fasting Plasma Glucose, and the Risk of Type 2 Diabetes: Results From the PREVEND Study
por: Post, Adrian, et al.
Publicado: (2022)

The relation between urinary sodium and potassium excretion and risk of cardiovascular events and mortality in patients with cardiovascular disease
por: Groenland, Eline H., et al.
Publicado: (2022)

GlycA, a novel pro‐inflammatory glycoprotein biomarker is associated with mortality: results from the PREVEND study and meta‐analysis
por: Gruppen, E. G., et al.
Publicado: (2019)

Low Urinary Creatinine Excretion Is Associated With Self-Reported Frailty in Patients With Advanced Chronic Kidney Disease
por: Polinder-Bos, Harmke A., et al.
Publicado: (2017)

Self‐Reported Smoking, Urine Cotinine, and Risk of Cardiovascular Disease: Findings From the PREVEND (Prevention of Renal and Vascular End‐Stage Disease) Prospective Cohort Study
por: Kunutsor, Setor K., et al.
Publicado: (2018)

Changes in urinary potassium excretion in patients with chronic kidney disease
por: Ueda, Yuichiro, et al.
Publicado: (2016)

Nephron mass determines the excretion rate of urinary extracellular vesicles
por: Blijdorp, Charles J., et al.
Publicado: (2022)

Acute acid load in chronic kidney disease increases plasma potassium, plasma aldosterone and urinary renin
por: Bovée, Dominique M, et al.
Publicado: (2020)

Vitamin B6, Inflammation, and Cardiovascular Outcome in a Population-Based Cohort: The Prevention of Renal and Vascular End-Stage Disease (PREVEND) Study
por: Minović, Isidor, et al.
Publicado: (2020)

Atrial fibrillation detected at screening is not a benign condition: outcomes in screen-detected versus clinically detected atrial fibrillation. Results from the Prevention of Renal and Vascular End-stage Disease (PREVEND) study
por: Zwartkruis, Victor W, et al.
Publicado: (2021)

Urinary Sodium and Potassium Excretion and Carotid Atherosclerosis in Chinese Men and Women
por: Dai, Xiao-Wei, et al.
Publicado: (2016)

Urinary Sodium and Potassium Excretion and Dietary Sources of Sodium in Maputo, Mozambique
por: Queiroz, Ana, et al.
Publicado: (2017)

Urinary Potassium Excretion and Progression From Advanced CKD to Kidney Failure
por: Hundemer, Gregory L., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1tfjhvlodvmsvg9n2dm1em599r